Amit Patel, MD
Sleep Medicine · Falls Church, VANPI 1346430519
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (29.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 92.3% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $5,058, more than ten times the $196 reported in 2019. Among sleep medicine clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 81 payments — averaging $167.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$13K
- Harmony Biosciences LLC$302
- Avadel CNS Pharmaceuticals, LLC$212
- Actelion Pharmaceuticals US, Inc.$80
- Johnson & Johnson$74
- Resmed Corp$51
- plus $327 from 14 others
Across 6 payments — averaging $1250.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inspire Medical Systems, Inc.$8K
What the payments were for
- Consulting fees$2,81321%
- Speaking & faculty fees$4,00029%
- Travel & lodging$3,55926%
- Food & beverage$3,12723%
- Education$801%
- Entertainment$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 47 | $12,548 |
| Harmony Biosciences LLC | 9 | $302 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $212 |
| Actelion Pharmaceuticals US, Inc. | 1 | $80 |
| Johnson & Johnson | 4 | $74 |
| Resmed Corp | 2 | $51 |
| Aerin Medical Inc. | 2 | $47 |
| Jazz Pharmaceuticals Inc. | 1 | $31 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Noctrix Health, Inc. | 1 | $30 |
| 3b Medical, Inc. | 1 | $24 |
| Novo Nordisk | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Merck | 1 | $17 |
| Itamar Medical Inc | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $16 |
| Gilead | 1 | $16 |
| Pfizer | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$7,304
- Inspire Upper Airway Stimulation System$4,534
- Wakix$124
- LUMRYZ$102
How this compares
$13,595 in reported general payments places this provider in the 90th percentile of 74 sleep medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 11 | $226,306 |
| QuviviqDaridorexant Hcl | 13 | $13,198 |
| Clonazepam | 15 | $694 |
| Methylphenidate Hcl | 12 | $595 |
| Doxepin Hcl | 23 | $532 |
| Gabapentin | 54 | $493 |
| Zolpidem Tartrate | 21 | $256 |
| Trazodone Hcl | 35 | $214 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Idorsia Pharmaceuticals US IncQuviviq | $30 | $13,19813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 74 sleep medicine providers in Virginia.
Other sleep medicine in Falls Church
- Astaad DalalFalls Church$99K
- Lawrence SteinFalls Church$3K
- Soumendro GoswamiFalls Church$2K
- Tajender VasuFalls Church$2K
- Jay KaufmanFalls Church$380
- William WinterCharlottesville$1.1M
- Michael PolskyNorth Chesterfield$99K
- Douglas PuryearMidlothian$49K
- Marc RaphaelsonLeesburg$47K
- Shahriar ShahzeidiLeesburg$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.